Bio Medica Laboratories Appoints Vishakha Agrawal & Associates as Secretarial Auditor
Bio Medica Laboratories Ltd 路 Change in Management 路 03 Sept 2026, 12:14 am
Bio Medica Laboratories Appoints Vishakha Agrawal & Associates as Secretarial Auditor Bio Medica Laboratories Ltd appointed M/s. Vishakha Agrawal & Associates as Secretarial Auditor, effective 2nd Sep'26. Approved by the Board, the appointment spans a consecutive five-year term from FY26 through FY30, pending shareholder approval at the upcoming Annual General Meeting. The Indore-based firm specializes in company law, securities regulations, and secretarial audits. This corporate governance update complies with SEBI LODR Regulation 30 requirements, noting no relationships exist between the newly appointed secretarial auditor and current company directors.
Original exchange filing (PDF)
More announcements from Bio Medica Laboratories Ltd
- Monitoring Agency Report for the half year ended 30th September, 2026, issued by CARE Ratings Limited ( Monitoring Agency ), in respect of the utilization of proceeds raised through Initial Public Offer by the Company 路 14 Nov 2026
- Bio Medica Laboratories Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 13 Nov 2026
- Un-Audited Standalone and Consolidated Financial Results along with Limited Review Report of the Company for the half year ended September 30, 2026 in terms of Regulation 33 of Securities and Exchange Board of India (Listing Obligation and Disclosure Requirement) 2015. 路 13 Nov 2026
- Bio Medica Laboratories Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 13 Nov 2026
- Bio Medica Laboratories Limited has informed the Exchange about Board Meeting to be held on 13-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2026 . 路 13 Nov 2026
- BMLL : 13-Nov-2026 : The Company has informed the Exchange that a Board meeting to be held on November 05, 2026 has been re-scheduled. Further, the Company has informed the Exchange that the meeting of the Board of Directors of the Company will be held on November 13, 2026, To consider and approve the financial results for the period ended September 30, 2026 路 13 Nov 2026
- Bio Medica Laboratories Limited has informed the Exchange about Board Meeting to be held on 05-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2026 . 路 05 Nov 2026
- To consider and approve the financial results for the period ended September 30, 2026 路 05 Nov 2026
